SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
4399Before I forget, I've failed to post an approval, sort of a cool one........scaram(o)uche6/21/2005
4398The 2005 Public Policy Institute of California report, The Dynamics of Californisjemmeri6/20/2005
4397Boston Globe editorial today.... STEVEN DICKMAN Biotech's $$$ problem By Strkrw6/18/2005
4396<i>One certainly can't argue with this week's result</i> Datom pope6/18/2005
4395I like it too ... Hope you Nailed AMLN. :) Looks alot like Sector Rotation toGalirayo6/18/2005
4394One certainly can't argue with this week's result. It has been so long Robohogs6/18/2005
4393Yup. And I like it. We've been way too long without sponsorship and fans, scaram(o)uche6/18/2005
4392LOL I assume you are referring to Cramer's touting of AMLN and MLNM? JonRobohogs6/18/2005
4391Give it your own definition..... companies having trouble getting on their indscaram(o)uche6/18/2005
4390Rick, What is <vestinmuck>? do you mean best-in-luck? -g-Extra Pale6/18/2005
4389guffaw. you may be correct. OTOH, we know that sponsorship is coming back to sscaram(o)uche6/17/2005
4388Bankers must be working the phones 'don't miss this window.' <i&keokalani'nui6/17/2005
4387US panel backs NitroMed heart drug for blacks Thu Jun 16, 2005 08:21 PM ET (Addscaram(o)uche6/16/2005
4386good stuff, thanks. (eom)scaram(o)uche6/16/2005
4385Signals looks at the industry at 2004 versus 1994: signalsmag.com Cheers, Tuctuck6/16/2005
43846/16/2005 GNT Italian pharmaceutical company Gentium prices at $9 Gentium, an Isjemmeri6/16/2005
4383Pfizer to Acquire Vicuron Pharmaceuticals to Extend its Research Commitment in Ascaram(o)uche6/16/2005
4382Genentech extends share buyback program Wed Jun 15, 2005 07:01 PM ET SAN FRANCIscaram(o)uche6/15/2005
4381that's a nice "heads up" to have here. thanks.scaram(o)uche6/15/2005
4380Novasite is the ex-amev small molecule co. Hauske is an ex-sepr exec, was headinrkrw6/15/2005
43796/13/2005 SNTA Drug developer Synta Pharmaceuticals withdraws IPO Synta Pharmasjemmeri6/14/2005
4378Halozyme Therapeutics Files $50M Mixed Securities Shelf DOW JONES NEWSWIRES Junmopgcw6/14/2005
4377Bernard: We don't generally discuss individual stocks in this thread. Herescaram(o)uche6/10/2005
4376Bad guess, sorry.tom pope6/10/2005
4375"Distressed assets? Workouts?" On a professional basis? Not at the cBernard Guerrero6/10/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News